Other Issues: Previous Next
International Journal of Hematology and Oncology 2010, Vol 20, Num 2 (Special Issue)

Ozlen BEKTAS, Ibrahim C. HAZNEDAROGLU, Yahya BUYUKASIK, Nilgun SAYINALP, Salih AKSU, Hakan GOKER, Osman I. OZCEBE Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML.UHOD , 2010 , 20 , 013-016
Turkish Abstract | Abstract | PDF | Similar Articles | Mail to Author | Mail to Editor |


Guray SAYDAM, Buket KOSOVA, Fahri SAHIN Successful Dasatinib Treatment in Chronic Myeloid Leukemia after Long-term Imatinib Failure: Case Report.UHOD , 2010 , 20 , 017-021
Turkish Abstract | Abstract | PDF | Similar Articles | Mail to Author | Mail to Editor |


Selda KAHRAMAN, Ozden PISKIN, Mehmet Ali OZCAN The Management of Second Generation Thyrosine Kinase Inhibitors Treatment: Case Report.UHOD , 2010 , 20 , 022-024
Turkish Abstract | Abstract | PDF | Similar Articles | Mail to Author | Mail to Editor |


Yahya BUYUKASIK, Ibrahim C. HAZNEDAROGLU, Osman ILHAN Chronic Myeloid Leukemia: Practical Issues in Diagnosis, Treatment and Follow-Up.UHOD , 2010 , 20 , 001-012
Turkish Abstract | Abstract | PDF | Similar Articles | Mail to Author | Mail to Editor |


Ibrahim C. HAZNEDAROGLU, Ebru KOCA, Salih AKSU, Hakan GOKER, Nilgun SAYINALP, Yahya BUYUKASIK, Osman I. OZCEBE The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations.UHOD , 2010 , 20 , 025-026
PDF | Mail to Author | Mail to Editor |